Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

ClinicalTrials.gov ID: NCT00117481

Public ClinicalTrials.gov record NCT00117481. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate DR-2001 for the Management of Moderate to Severe Endometriosis-Related Nonmenstrual Pelvic Pain

Study identification

NCT ID
NCT00117481
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duramed Research
Industry
Enrollment
90 participants

Conditions and interventions

Conditions

Interventions

  • DR-2001a Drug
  • DR-2001b Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007
Last update posted
May 8, 2014

2005 – 2007

United States locations

U.S. sites
41
U.S. states
23
U.S. cities
41
Facility City State ZIP Site status
Duramed Investigational Site Enterprise Alabama 36330
Duramed Investigational Site Montgomery Alabama 53717
Duramed Investigational Site Phoenix Arizona 85032
Duramed Investigational Site Tucson Arizona 85712
Duramed Investigational Site Little Rock Arkansas 72205
Duramed Investigational Site La Jolla California 92093
Duramed Investigational Site San Diego California 92103
Duramed Investigational Site Vista California 92083
Duramed Investigational Site Colorado Springs Colorado 80909
Duramed Investigational Site Clearwater Florida 33759
Duramed Investigational Site Hudson Florida 34667
Duramed Investigational Site Spring Hill Florida 34609
Duramed Investigational Site Tampa Florida 33606
Duramed Investigational Site West Palm Beach Florida 33409
Duramed Investigational Site Decatur Georgia 30034
Duramed Investigational Site Idaho Falls Idaho 83404
Duramed Investigational Site La Grange Park Illinois 60526
Duramed Investigational Site Maywood Illinois 60153
Duramed Investigational Site Oak Brook Illinois 60523
Duramed Investigational Site Louisville Kentucky 40291
Duramed Investigational Site Ann Arbor Michigan 48109
Duramed Investigational Site Reno Nevada 89502
Duramed Investigational Site Princeton New Jersey 08502
Duramed Investigational Site Port Jefferson New York 11777
Duramed Investigational Site Chapel Hill North Carolina 27599
Duramed Investigational Site Morganton North Carolina 28655
Duramed Investigational Site Winston-Salem North Carolina 27103
Duramed Investigational Site Columbus Ohio 43210
Duramed Investigational Site Dayton Ohio 45432
Duramed Investigational Site Oklahoma City Oklahoma 73112
Duramed Investigational Site Jenkintown Pennsylvania 36116
Duramed Investigational Site Florence South Carolina 29501
Duramed Investigational Site Jackson Tennessee 38305
Duramed Investigational Site Memphis Tennessee 38120
Duramed Investigational Site Austin Texas 78737
Duramed Investigational Site Dallas Texas 75231
Duramed Investigational Site San Antonio Texas 78229
Duramed Investigational Site Pleasant Grove Utah 84062
Duramed Investigational Site Sandy City Utah 84070
Duramed Investigational Site Norfolk Virginia 23607
Duramed Investigational Site Virginia Beach Virginia 23456

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00117481, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00117481 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →